Bio-Techne (TECH) FY2012 results: revenue $315 million, up 8.5% on the year
Bio-Techne Corp. (TECH) reported revenue of $315 million for fiscal 2012, the year ended 30 June 2012, up 8.5% on the year before. Net income was $112 million, unchanged, and diluted earnings per share $0.76. The figures are the company's own, from the 10-K it filed with the SEC on 29 August 2012.
Revenue
$315 million
+8.5% on the year
FY2009FY2012
Operating margin
52.8%
56.2% a year earlier
FY2009FY2012
Net income
$112 million
+0.0% on the year
FY2009FY2012
Diluted EPS
$0.76
+0.7% on the year
FY2009FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
315
290
269
+8.5%
Cost of revenue
78.8
65.0
54.9
+21.1%
Gross profit
236
225
214
+4.8%
Gross margin
75.0%
77.6%
79.6%
Research and development
27.9
26.0
25.1
+7.4%
Selling, general and administrative
41.7
35.9
32.7
+16.1%
Operating income
166
163
156
+1.9%
Operating margin
52.8%
56.2%
58.1%
Pre-tax income
162
165
156
-1.7%
Income tax
49.9
52.7
46.7
-5.3%
Effective tax rate
30.7%
31.9%
29.8%
Net income
112
112
110
+0.0%
Net margin
35.7%
38.7%
40.8%
Diluted EPS
$0.76
$0.76
$0.73
+0.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
127
127
111
-0.4%
Capital expenditure
6.0
3.6
4.6
+65.8%
Free cash flow
121
124
107
-2.3%
Free cash flow margin
38.4%
42.6%
39.6%
Cash from investing
-21.7
-114
-115
Cash from financing
-64.6
-36.3
-50.5
Depreciation and amortisation
12.5
8.7
8.1
+43.3%
Share-based compensation
n/a
1.1
1.1
Buybacks
23.6
1.9
15.0
+1,116.4%
Dividends paid
41.0
39.7
38.4
+3.3%
Dividend per share
$0.28
$0.27
$0.26
+3.7%
Diluted shares, weighted
148m
149m
149m
-0.4%
Shares outstanding at period end
147m
149m
148m
-0.9%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
674
586
502
+15.1%
Debt
0.0
0.0
0.0
Other liabilities
44.9
31.5
17.0
+42.3%
Total liabilities and equity
719
618
519
+16.5%
Fixed assets
93.8
95.4
97.4
-1.7%
Goodwill
85.7
86.6
25.1
-1.1%
Intangible assets
46.5
52.3
2.0
-11.1%
Investments
296
195
216
+51.8%
Cash and equivalents
117
77.6
94.1
+50.3%
Receivables
35.7
35.9
30.9
-0.7%
Inventory
38.3
44.9
13.7
-14.8%
Other assets
6.5
29.7
39.7
-78.2%
Total assets
719
618
519
+16.5%
10-K for the year ended 30 June 2012, filed 29 August 2012: the filing.